September 2, 2014

MedAssets, Inc. acquires market intelligence and strategic analytics platform to enrich its leadership in performance improvement.

Willkie client MedAssets, Inc. recently announced it signed a definitive agreement to acquire privately held SG-2, LLC for approximately $142 million.  Based in Skokie, Ill., Sg2 is a leading provider of healthcare market intelligence, strategic analytics and clinical consulting services, assisting more than 1,400 hospitals, health systems and pharmaceutical and medical device companies understand current and future market dynamics.   MedAssets, based in Alpharetta, GA,  is a healthcare performance improvement company focused on helping providers realize financial and operational gains. More than 4,400 hospitals and 122,000 non-acute healthcare providers currently use the company's evidence-based solutions, best practice processes and analytics.  

Led by partner Morgan Elwyn, the multidisciplinary Willkie team included: Corporate:  partner William Dye and associates Manuel Miranda, Susannah Ostlund and Caleb Vesey; IP: partner  Eugene Chang and associates Amir Ghavi and Alexandra Awai; Benefits: partner Michael Katz and associates Geri Anne McEvoy and Ryan Stott and Tax: partner Hillel Jacobson.